GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PCI Biotech Holding ASA (STU:4QG) » Definitions » ROC (Joel Greenblatt) %

PCI Biotech Holding ASA (STU:4QG) ROC (Joel Greenblatt) % : -1,378.34% (As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is PCI Biotech Holding ASA ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. PCI Biotech Holding ASA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -1,378.34%.

The historical rank and industry rank for PCI Biotech Holding ASA's ROC (Joel Greenblatt) % or its related term are showing as below:

STU:4QG' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -429066.67   Med: -90861.4   Max: -1006.4
Current: -2622.51

During the past 13 years, PCI Biotech Holding ASA's highest ROC (Joel Greenblatt) % was -1006.40%. The lowest was -429066.67%. And the median was -90861.40%.

STU:4QG's ROC (Joel Greenblatt) % is ranked worse than
78.93% of 1462 companies
in the Biotechnology industry
Industry Median: -329.055 vs STU:4QG: -2622.51

PCI Biotech Holding ASA's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 45.40% per year.


PCI Biotech Holding ASA ROC (Joel Greenblatt) % Historical Data

The historical data trend for PCI Biotech Holding ASA's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCI Biotech Holding ASA ROC (Joel Greenblatt) % Chart

PCI Biotech Holding ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,798.41 -981.48 -1,152.45 -1,274.76 -3,688.42

PCI Biotech Holding ASA Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,859.11 -2,761.54 -1,896.83 -1,378.34 -

Competitive Comparison of PCI Biotech Holding ASA's ROC (Joel Greenblatt) %

For the Biotechnology subindustry, PCI Biotech Holding ASA's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PCI Biotech Holding ASA's ROC (Joel Greenblatt) % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PCI Biotech Holding ASA's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where PCI Biotech Holding ASA's ROC (Joel Greenblatt) % falls into.



PCI Biotech Holding ASA ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Mar. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.52 + 0 + -8.8817841970013E-16) - (0.022 + 0 + 0.402)
=0.095999999999999

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.547 + 0 + 0) - (0.207 + 0 + 0.224)
=0.116

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of PCI Biotech Holding ASA for the quarter that ended in Jun. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Jun. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2023  Q: Jun. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-2.164/( ( (0.056 + max(0.095999999999999, 0)) + (0.046 + max(0.116, 0)) )/ 2 )
=-2.164/( ( 0.152 + 0.162 )/ 2 )
=-2.164/0.157
=-1,378.34 %

Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PCI Biotech Holding ASA  (STU:4QG) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


PCI Biotech Holding ASA ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of PCI Biotech Holding ASA's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


PCI Biotech Holding ASA (STU:4QG) Business Description

Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, N-0379
PCI Biotech Holding ASA is a biopharmaceutical company. It focuses on developing and commercializing therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The PCI technology works by inducing light-triggered endosomal release. PCI is applied to three distinct anticancer paradigms; fimaCHEM which is an enhancement of chemotherapeutics for localized treatment of cancer, fimaVACC which is T-cell induction technology for therapeutic vaccination, and fimaNAc which is nucleic acid therapeutics delivery. Its therapeutic product candidate is the photosensitizer fimaporfin (Amphinex) which can unlock the intracellular capsules where active compounds are trapped.

PCI Biotech Holding ASA (STU:4QG) Headlines

No Headlines